Doxorubicin-Conjugated PAMAM Dendrimers for pH-Responsive Drug Release and Folic Acid-Targeted Cancer Therapy

We present here the development of multifunctional doxorubicin (DOX)-conjugated poly(amidoamine) (PAMAM) dendrimers as a unique platform for pH-responsive drug release and targeted chemotherapy of cancer cells. In this work, we covalently conjugated DOX onto the periphery of partially acetylated and...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Mengen, Zhu, Jingyi, Zheng, Yun, Guo, Rui, Wang, Shige, Mignani, Serge, Caminade, Anne-Marie, Majoral, Jean-Pierre, Shi, Xiangyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160908/
https://www.ncbi.nlm.nih.gov/pubmed/30235881
http://dx.doi.org/10.3390/pharmaceutics10030162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160908/
https://www.ncbi.nlm.nih.gov/pubmed/30235881
http://dx.doi.org/10.3390/pharmaceutics10030162

Ejemplares similares